Piotr Smolewski

1960 - 2023

country of citizenship: Poland

native language: Polish

languages spoken, written or signed: Polish

occupation: researcher, hematologist, university teacher

award received: Cross of Merit, Gold Cross of Merit‎ (Poland), Medal 65-lecia Wyższego Szkolnictwa Medycznego w Łodzi

Piotr Paweł Smolewski (ur. 25 grudnia 1960 w Łodzi, zm. 20 marca 2023) – polski hematolog, wykładowca na Uniwersytecie Medycznym w Łodzi. Source: Wikipedia (pl)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 139

Date

Title

Authors

2022-02-02

The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions

Piotr Smolewski, Tadeusz Robak
2021-02-18

Advances in the pharmacotherapeutic options for primary nodal peripheral T-cell lymphoma

Piotr Smolewski, Tadeusz Robak
2021-06

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Monika Długosz-Danecka, Piotr Smolewski, Martin Hutchings, Nancy L Bartlett, Ewa Lech-Marańda, Ranjana H. Advani, John Radford, Jan Walewski, Joseph M Connors, Marco Picardi, Tatyana Feldman, Kerry J Savage, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Stephen M Ansell, Anas Younes, Andrea Gallamini, Rachael Liu, Michelle A Fanale
2021-12-23

Comparison of various diagnostic methods in assessing platelet count in patients with immune thrombocytopenia

Magdalena Witkowska, Piotr Smolewski, Tadeusz Robak
2021-11-08

Dealing with hypodysfibrinogenemia during pregnancy with a successful outcome

Magdalena Witkowska, Piotr Smolewski, Tadeusz Robak
2021

Der Stand der Therapie bei der refraktären/rezidivierenden chronischen lymphatischen Leukämie: Neuartige Wirkstoffe im Fokus

Piotr Smolewski, Tadeusz Robak
2021-07-14

Quality of life patients treated with rituximab intravenous versus subcutaneous in B-cell lymphomas: results from outpatient Hematooncology Clinic in Lodz

Magdalena Witkowska, Piotr Smolewski
2021-02-25

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib

Damian Mikulski, Dariusz Jarych, Konrad Stawiski, Piotr Smolewski, Wojciech Fendler, Tadeusz Robak
2021-05-06

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients

Agnieszka Wierzbowska, Piotr Smolewski, Tadeusz Robak
2020-03-01

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

Nancy L Bartlett, John Radford, Martin Hutchings, Ewa Lech-Marańda, Jan Walewski, Piotr Smolewski, Monika Długosz-Danecka, Ranjana H. Advani, Andrea Gallamini, Anas Younes, Marco Picardi, Tatyana Feldman, Kerry J Savage, Radhakrishnan Ramchandren, Rachael Liu
2020-06-06

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib

Damian Mikulski, Piotr Smolewski, Tadeusz Robak, Wojciech Fendler, Dariusz Jarych, Janusz Szemraj, Ewa Wawrzyniak, Małgorzata Misiewicz, Pawel Robak, Edyta Węgłowska, Izabela Drozdz, Magdalena Ferlińska
2020-07-20

Efficacy and safety of idelalisib for the treatment of indolent B-cell malignancies

Piotr Smolewski
2020-09-09

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients

Dariusz Jarych, Damian Mikulski, Konrad Stawiski, Tadeusz Robak, Piotr Smolewski, Wojciech Fendler, Janusz Szemraj, Małgorzata Misiewicz, Pawel Robak, Edyta Węgłowska, Izabela Drozdz
2019-04-25

Mantle cell lymphoma: therapeutic options in transplant-ineligible patients

Tadeusz Robak, Piotr Smolewski
2019-06-14

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group

Joanna Drozd-Sokolowska, Jan Maciej Zaucha, Tomasz Żółtak, Anna Waszczuk-Gajda, Iwona Hus, Jacek Kwiatkowski, Andrzej Szczepaniak, Anna Kopińska, Wiesław Jędrzejczak, Sebastian Giebel, Kazimierz Halaburda, Krzysztof Jamroziak, Piotr Smolewski, Dariusz Wolowiec, Olga Grzybowska-Izydorczyk, Wanda Knopinska-Posluszny, Jadwiga Hołojda, Magdalena Witkowska
2019-01-01

Roux-en-Y gastric bypass as a cure of iatrogenic - steroid induced diabetes

Leszek Czupryniak, Janusz Strzelczyk, Piotr Hogendorf, Adam Durczynski, Piotr Smolewski
2019-08-02

Clinical management of mantle cell lymphoma in the elderly

Tadeusz Robak, Piotr Smolewski
2019-04-13

Ixazomib: an investigational drug for the treatment of lymphoproliferative disorders

Piotr Smolewski
2019-08-23

The role of neuronal apoptosis inhibitory protein (NAIP) in acute myeloid leukemia patients

Agnieszka Wierzbowska, Barbara Cebula-Obrzut, Piotr Smolewski, Tadeusz Robak
2018-04-11

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas

Magdalena Witkowska, Piotr Smolewski
2018-12-10

Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells

Katarzyna Lubecka, Barbara Cebula-Obrzut, Piotr Smolewski, Janusz Szemraj, Krystyna Fabianowska-Majewska, Agnieszka Kaufman-Szymczyk
2018-01-15

Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies

Magdalena Witkowska, Tadeusz Robak, Piotr Smolewski
2018-03-22

Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial

Tadeusz Robak, Tomasz Wróbel, Lukasz Bolkun, Bozena Katarzyna Budziszewska, Janusz Kłoczko, Piotr Smolewski, Jerzy Z. Blonski
2017-12-13

Evaluation of the usefulness of smartphone-directed applications for measuring heart rate and arrhythmia detection

Magdalena Witkowska, Piotr Smolewski, Andrzej Bissinger, Andrzej Lubiński
2017-08-09

Emerging antibody-drug conjugates for treating lymphoid malignancies

Tadeusz Robak, Piotr Smolewski, Pawel Robak
2017-06-22

The discovery and development of romidepsin for the treatment of T-cell lymphoma

Tadeusz Robak, Piotr Smolewski
2017-03-01

The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia

Magdalena Witkowska, Barbara Cebula-Obrzut, Tadeusz Robak, Piotr Smolewski, Agata Majchrzak, Ewa Wawrzyniak
2017-12-10

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

John Radford, Wojciech Jurczak, Ewa Lech-Marańda, Nancy L Bartlett, Jan Walewski, Pier Luigi Zinzani, Piotr Smolewski, Armando Santoro, Andrea Gallamini, Anas Younes, Marco Picardi, Tatyana Feldman, Kerry J Savage, Radhakrishnan Ramchandren, Rachael Liu, Dirk Huebner, David Cunningham
2017-10-01

Successful hemihepatectomy following chemotherapy for primary liver lymphoma: case report and review of literature.

Adam Durczynski, Janusz Strzelczyk, Piotr Hogendorf, Aleksander Skulimowski, Piotr Smolewski
2017-10-01

The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus.

Tadeusz Robak, Barbara Cebula-Obrzut, Piotr Smolewski, Ewa Robak, Agnieszka Klonowska-Szymczyk
2016-04

Inhibitory immunologicznych punktów kontrolnych podziału komórki w leczeniu chorób nowotworowych

Piotr Smolewski
2016-07

Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2016 r – Raport Grupy Roboczej PTHiT i PALG-CLL

Iwona Hus, Piotr Smolewski, Krzysztof Giannopoulos, Krzysztof Jamroziak, Tadeusz Robak, Dariusz Wolowiec

Human - wd:Q88929410

Welcome to Inventaire

the library of your friends and communities

learn more